GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

pathways in human cancer

pathways : pathways in human cancer pathways:

Fullview (zoomIn)


Related Pathways to "pathways in human cancer" content :


Related Genes to "pathways in human cancer" content :

preload


Related products :

Catalog number Product name Quantity
25-651 Electron transport pathways are generally associated with mitochondrial membranes, but non-mitochondrial pathways are also biologically significant. Plasma membrane electron transport pathways are inv 0.05 mg
29-002 NR2E3 is part of a large family of nuclear receptor transcription factors involved in signaling pathways. Nuclear receptors have been shown to regulate pathways involved in embryonic development, as w 0.1 mg
3405 (IN2) An intermediate in the TLR and Bmp signaling pathways 0.1 mg
3377 (CT) An intermediate in the TLR and Bmp signaling pathways 0.1 mg
3377 (CT) An intermediate in the TLR and Bmp signaling pathways 0.5 mg
3405 (IN2) An intermediate in the TLR and Bmp signaling pathways 0.5 mg
orb81973 Human CA125 LCR Calib. Grade protein Cancer Antigen CA125 (Ovarian Cancer) Calibrator Grade (Low Cross Reactivity) is a purified reagent for cancer research. For research use only. 50 KU
orb82081 Human CA125 LCR Calib. Grade protein Cancer Antigen CA125 (Ovarian Cancer) Calibrator Grade (Low Cross Reactivity) is a purified reagent for cancer research. For research use only. 50 KU
orb82268 Human CA125 LCR Calib. Grade protein Cancer Antigen CA125 (Ovarian Cancer) Calibrator Grade (Low Cross Reactivity) is a purified reagent for cancer research. For research use only. 250 KU
orb81971 Human CA15-3 LCR Calib. Grade protein Cancer Antigen CA15-3 (Breast Cancer) Calibrator Grade (Low Cross Reactivity) is a purified reagent for cancer research. For research use only. 50 KU
orb81970 Human CA125 Calib. Grade LCR protein Cancer Antigen CA125 (Ovarian Cancer) Calibrator Grade (Low Cross Reactivity) is a purified reagent for cancer research. For research use only. 50 KU
orb82082 Human CA19-9 LCR Calib. Grade protein Cancer Antigen CA19-9 (Gastrointestinal Cancer) Calibrator Grade (Low Cross is a purified reagent for cancer research. For research use only. 50 KU
orb81978 Human CA15-3 Calib. Grade protein Cancer Antigen CA15-3 (Breast Cancer) Calibrator Grade is a purified reagent for cancer research. For research use only. 50 KU
4-28038 Human Cancer PrimaCell™15: Skin Cancer Cells, primary cell culture Kit
2-96038 Human Cancer PrimaCell™15: Skin Cancer Cells, primary cell culture Kit
9-46038 Human Cancer PrimaCell™15: Skin Cancer Cells, primary cell culture 5 x 100 ml
9-80038 Human Cancer PrimaCell™15: Skin Cancer Cells, primary cell culture 1 x 100 ml
9-47038 Human Cancer PrimaCell™15: Skin Cancer Cells, primary cell culture set
DCAB-TJ236 Mouse anti Human Cancer Antigen CA19-9 (Gastrointestinal Cancer) Monoclonal Antibody inquire
DCAB-TJ235 Mouse anti Human Cancer Antigen CA19-9 (Gastrointestinal Cancer) Monoclonal Antibody inquire
DCAB-TJ237 Mouse anti Human Cancer Antigen CA19-9 (Gastrointestinal Cancer) Monoclonal Antibody inquire
orb81967 Human Cancer Antigen CA15-3 Antigen Grade protein Cancer Antigen CA15-3 (Breast Cancer) Antigen Grade is a purified reagent for cancer research. For research use only. 50 KU
orb82297 Cancer Ag CA19-9 Calib. Grade protein Cancer Antigen CA19-9 (Gastrointestinal Cancer) Calibrator Grade is a purified reagent for cancer research. For research use only. 50 KU
A43350H Cancer Antigen CA125 (Ovarian Cancer) Calibrator Grade (Low Cross Reactivity) host: Human Fluids 50ku
orb61244 Erlotinib Erlotinib hydrochloride is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer. For research use only. 100 mg

Pathways :

WP2107: pathways in human cancer
WP232: G Protein Signaling Pathways
WP1770: One carbon metabolism and related pathways
WP749: Myometrial Relaxation and Contraction Pathways
WP1904: RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
WP931: G Protein Signaling Pathways
WP1049: G Protein Signaling Pathways
WP2361: Gastric cancer network 1
WP112: Principle Pathways of Carbon Metabolism
WP2377: Integrated Pancreatic Cancer Pathway
WP1984: Integrated Breast Cancer Pathway
WP975: Myometrial Relaxation and Contraction Pathways
WP1266: SIDS Susceptibility Pathways
WP289: Myometrial Relaxation and Contraction Pathways
WP1371: G Protein Signaling Pathways
WP385: Myometrial Relaxation and Contraction Pathways
WP2256: Integrated Pancreatic Cancer Pathway
WP2291: Deregulation of Rab and Rab Effector Genes in Bladder Cancer
WP1589: Folate-Alcohol and Cancer Pathway
WP73: G Protein Signaling Pathways
WP1901: Regulatory RNA pathways
WP857: Myometrial Relaxation and Contraction Pathways
WP2335: sGC Cancer
WP1093: Myometrial Relaxation and Contraction Pathways
WP2367: Private Pancreatic Cancer

Related Genes :
[MAP3K20 MLTK ZAK HCCS4] Mitogen-activated protein kinase kinase kinase 20 (EC 2.7.11.25) (Human cervical cancer suppressor gene 4 protein) (HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mitogen-activated protein kinase kinase kinase MLT) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK)
[SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6] C-Jun-amino-terminal kinase-interacting protein 4 (JIP-4) (JNK-interacting protein 4) (Cancer/testis antigen 89) (CT89) (Human lung cancer oncogene 6 protein) (HLC-6) (JNK-associated leucine-zipper protein) (JLP) (Mitogen-activated protein kinase 8-interacting protein 4) (Proliferation-inducing protein 6) (Protein highly expressed in testis) (PHET) (Sperm surface protein) (Sperm-associated antigen 9) (Sperm-specific protein) (Sunday driver 1)
[RACK1 GNB2L1 HLC7 PIG21] Receptor of activated protein C kinase 1 (Cell proliferation-inducing gene 21 protein) (Guanine nucleotide-binding protein subunit beta-2-like 1) (Guanine nucleotide-binding protein subunit beta-like protein 12.3) (Human lung cancer oncogene 7 protein) (HLC-7) (Receptor for activated C kinase) (Small ribosomal subunit protein RACK1) [Cleaved into: Receptor of activated protein C kinase 1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed)]
[AKAP13 BRX HT31 LBC] A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47)
[MAEA EMP HLC10 PIG5] E3 ubiquitin-protein transferase MAEA (EC 2.3.2.27) (Cell proliferation-inducing gene 5 protein) (Erythroblast macrophage protein) (Human lung cancer oncogene 10 protein) (HLC-10) (Macrophage erythroblast attacher) (P44EMLP)
[NDUFC2 HLC1] NADH dehydrogenase [ubiquinone] 1 subunit C2 (Complex I-B14.5b) (CI-B14.5b) (Human lung cancer oncogene 1 protein) (HLC-1) (NADH-ubiquinone oxidoreductase subunit B14.5b)
[ANKRD17 GTAR KIAA0697] Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16)
[BRCA1 RNF53] Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1)
[MUC1 PUM] Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)]
[BRCA2 FACD FANCD1] Breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein)
[TFF1 BCEI PS2] Trefoil factor 1 (Breast cancer estrogen-inducible protein) (PNR-2) (Polypeptide P1.A) (hP1.A) (Protein pS2)
[TACC1 KIAA1103] Transforming acidic coiled-coil-containing protein 1 (Gastric cancer antigen Ga55) (Taxin-1)
[NCOA3 AIB1 BHLHE42 RAC3 TRAM1] Nuclear receptor coactivator 3 (NCoA-3) (EC 2.3.1.48) (ACTR) (Amplified in breast cancer 1 protein) (AIB-1) (CBP-interacting protein) (pCIP) (Class E basic helix-loop-helix protein 42) (bHLHe42) (Receptor-associated coactivator 3) (RAC-3) (Steroid receptor coactivator protein 3) (SRC-3) (Thyroid hormone receptor activator molecule 1) (TRAM-1)
[CENPW C6orf173 CUG2] Centromere protein W (CENP-W) (Cancer-up-regulated gene 2 protein)
[SH3KBP1 CIN85] SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1)
[SLC4A1AP HLC3] Kanadaptin (Human lung cancer oncogene 3 protein) (HLC-3) (Kidney anion exchanger adapter protein) (Solute carrier family 4 anion exchanger member 1 adapter protein)
[NDFIP1 N4WBP5 PSEC0192 PSEC0223] NEDD4 family-interacting protein 1 (Breast cancer-associated protein SGA-1M) (NEDD4 WW domain-binding protein 5) (Putative MAPK-activating protein PM13) (Putative NF-kappa-B-activating protein 164) (Putative NFKB and MAPK-activating protein)
[NUCB2 NEFA] Nucleobindin-2 (DNA-binding protein NEFA) (Epididymis secretory protein Li 109) (Gastric cancer antigen Zg4) (Prepronesfatin) [Cleaved into: Nesfatin-1]
[MAP3K8 COT ESTF] Mitogen-activated protein kinase kinase kinase 8 (EC 2.7.11.25) (Cancer Osaka thyroid oncogene) (Proto-oncogene c-Cot) (Serine/threonine-protein kinase cot) (Tumor progression locus 2) (TPL-2)
[TRIP13 PCH2] Pachytene checkpoint protein 2 homolog (Human papillomavirus type 16 E1 protein-binding protein) (16E1-BP) (HPV16 E1 protein-binding protein) (Thyroid hormone receptor interactor 13) (Thyroid receptor-interacting protein 13) (TR-interacting protein 13) (TRIP-13)
[KNL1 CASC5 KIAA1570] Kinetochore scaffold 1 (ALL1-fused gene from chromosome 15q14 protein) (AF15q14) (Bub-linking kinetochore protein) (Blinkin) (Cancer susceptibility candidate gene 5 protein) (Cancer/testis antigen 29) (CT29) (Kinetochore-null protein 1) (Protein CASC5) (Protein D40/AF15q14)
[SDCCAG8 CCCAP NPHP10 HSPC085] Serologically defined colon cancer antigen 8 (Antigen NY-CO-8) (Centrosomal colon cancer autoantigen protein) (hCCCAP)
[NCOA6 AIB3 KIAA0181 RAP250 TRBP] Nuclear receptor coactivator 6 (Activating signal cointegrator 2) (ASC-2) (Amplified in breast cancer protein 3) (Cancer-amplified transcriptional coactivator ASC-2) (Nuclear receptor coactivator RAP250) (NRC RAP250) (Nuclear receptor-activating protein, 250 kDa) (Peroxisome proliferator-activated receptor-interacting protein) (PPAR-interacting protein) (PRIP) (Thyroid hormone receptor-binding protein)
[DLEC1 DLC1] Deleted in lung and esophageal cancer protein 1 (Deleted in lung cancer protein 1) (DLC-1)
[CDK2AP1 CDKAP1 DOC1] Cyclin-dependent kinase 2-associated protein 1 (CDK2-associated protein 1) (Deleted in oral cancer 1) (DOC-1) (Putative oral cancer suppressor)
[LETMD1] LETM1 domain-containing protein 1 (Cervical cancer 1 proto-oncogene protein p40) (Cervical cancer proto-oncogene 2 protein) (HCCR-1) (HCRR-2)
[STEAP2 PCANAP1 STAMP1 UNQ6507/PRO23203] Metalloreductase STEAP2 (EC 1.16.1.-) (Prostate cancer-associated protein 1) (Protein up-regulated in metastatic prostate cancer) (PUMPCn) (Six-transmembrane epithelial antigen of prostate 2) (SixTransMembrane protein of prostate 1)
[Map3k20 Mltk Zak] Mitogen-activated protein kinase kinase kinase 20 (EC 2.7.11.25) (Human cervical cancer suppressor gene 4 protein) (HCCS-4) (Leucine zipper- and sterile alpha motif kinase ZAK) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mitogen-activated protein kinase kinase kinase MLT) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK)
[ELAC2 HPC2] Zinc phosphodiesterase ELAC protein 2 (EC 3.1.26.11) (ElaC homolog protein 2) (Heredity prostate cancer protein 2) (Ribonuclease Z 2) (RNase Z 2) (tRNA 3 endonuclease 2) (tRNase Z 2)
[CCAR2 DBC1 KIAA1967] Cell cycle and apoptosis regulator protein 2 (Cell division cycle and apoptosis regulator protein 2) (DBIRD complex subunit KIAA1967) (Deleted in breast cancer gene 1 protein) (DBC-1) (DBC.1) (NET35) (p30 DBC)

Bibliography :
[31317835] An Overview on ATP Dependent and Independent Proteases Including an Anterograde to Retrograde Control on Mitochondrial Function; Focus on Diabetes and Diabetic Complications.
[31317376] Dopaminergic Pathways in Obesity-Associated Inflammation.
[31317050] Different roles of peroxisome proliferator-activated receptor gamma isoforms in prostate cancer.
[31316002] Eukaryotic initiation factor 3, subunit C silencing inhibits cell proliferation and promotes apoptosis in human ovarian cancer cells.
[31315892] Expression of the type 3 InsP receptor is a final common event in the development of hepatocellular carcinoma.
[31315786] [Therapeutic Relevance of Human Microbiota and Lung Cancer].
[31313878] The genetics of human hematopoiesis and its disruption in disease.
[31313132] Targeting the phosphoinositide 3-kinase/AKT pathways by small molecules and natural compounds as a therapeutic approach for breast cancer cells.
[31313023] Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells.
[31311925] Membrane protein-regulated networks across human cancers.